Pulmonx (LUNG) Operating Leases (2019 - 2025)

Pulmonx (LUNG) has 7 years of Operating Leases data on file, last reported at $18.1 million in Q4 2025.

• On a quarterly basis, Operating Leases fell 2.46% year-over-year to $18.1 million in Q4 2025; TTM through Dec 2025 was $18.1 million, a 2.46% decrease from a year earlier, with the FY2025 full-year figure at $18.1 million, down 2.46% from the prior year.
• Operating Leases for Q4 2025 stood at $18.1 million, down from $19.4 million in the prior quarter.
• Over the last five years, Operating Leases for LUNG reached as high as $19.8 million in Q1 2025 and fell as low as $650000.0 in Q1 2024.
• Historically, Operating Leases has averaged $10.3 million across 5 years, with a median of $7.7 million in 2021.
• Across the five-year window, Operating Leases slumped 89.71% in 2024 and soared 2938.92% in 2025, its largest moves.
• Year by year, Operating Leases stood at $6.8 million in 2021, then slumped by 43.76% to $3.8 million in 2022, then tumbled by 71.27% to $1.1 million in 2023, then surged by 1574.05% to $18.5 million in 2024, then decreased by 2.46% to $18.1 million in 2025.
• Per Business Quant data, the three most recent Operating Leases figures were $18.1 million in Q4 2025, $19.4 million in Q3 2025, and $18.6 million in Q2 2025.